InvestorsHub Logo
Followers 20
Posts 1059
Boards Moderated 0
Alias Born 04/01/2013

Re: sts66 post# 199744

Wednesday, 07/03/2019 1:03:26 PM

Wednesday, July 03, 2019 1:03:26 PM

Post# of 426987
They can wait until after FDA approval and do it higher if that is the route. Realistically since they cannot do a large direct to consumer until Q2 2020 the cash and cash flow they have now should negate need for a raise this year, and perhaps script growth will negate need by Q2 2020.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News